HRP20080529T3 - Amide prodrug of gemcitabine, compositions and use thereof - Google Patents

Amide prodrug of gemcitabine, compositions and use thereof

Info

Publication number
HRP20080529T3
HRP20080529T3 HR20080529T HRP20080529T HRP20080529T3 HR P20080529 T3 HRP20080529 T3 HR P20080529T3 HR 20080529 T HR20080529 T HR 20080529T HR P20080529 T HRP20080529 T HR P20080529T HR P20080529 T3 HRP20080529 T3 HR P20080529T3
Authority
HR
Croatia
Prior art keywords
gemcitabine
compositions
amide prodrug
prodrug
amide
Prior art date
Application number
HR20080529T
Other languages
English (en)
Croatian (hr)
Inventor
Michael Bender David
Michael Remick David
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HRP20080529T3 publication Critical patent/HRP20080529T3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/073Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
HR20080529T 2004-12-17 2008-10-21 Amide prodrug of gemcitabine, compositions and use thereof HRP20080529T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63742204P 2004-12-17 2004-12-17
PCT/US2005/043125 WO2006065525A1 (en) 2004-12-17 2005-11-30 Amide prodrug of gemcitabine, compositions and use thereof

Publications (1)

Publication Number Publication Date
HRP20080529T3 true HRP20080529T3 (en) 2008-12-31

Family

ID=36168678

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080529T HRP20080529T3 (en) 2004-12-17 2008-10-21 Amide prodrug of gemcitabine, compositions and use thereof

Country Status (32)

Country Link
US (1) US7691827B2 (no)
EP (1) EP1831237B1 (no)
JP (1) JP5022911B2 (no)
KR (1) KR100874052B1 (no)
CN (1) CN101080417B (no)
AR (1) AR055009A1 (no)
AT (1) ATE405573T1 (no)
AU (1) AU2005316922B2 (no)
BR (1) BRPI0519117A2 (no)
CA (1) CA2589850C (no)
CY (1) CY1108447T1 (no)
DE (1) DE602005009255D1 (no)
DK (1) DK1831237T3 (no)
EA (1) EA011868B1 (no)
ES (1) ES2310860T3 (no)
HK (1) HK1109903A1 (no)
HR (1) HRP20080529T3 (no)
IL (1) IL183666A (no)
MA (1) MA29154B1 (no)
MX (1) MX2007007228A (no)
MY (1) MY143677A (no)
NO (1) NO20073368L (no)
NZ (1) NZ554732A (no)
PE (1) PE20060771A1 (no)
PL (1) PL1831237T3 (no)
PT (1) PT1831237E (no)
RS (1) RS50629B (no)
SI (1) SI1831237T1 (no)
TW (1) TWI326687B (no)
UA (1) UA86119C2 (no)
WO (1) WO2006065525A1 (no)
ZA (1) ZA200705019B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA014909B1 (ru) * 2006-06-21 2011-02-28 Эли Лилли Энд Компани Кристаллические формы пролекарства на основе амида гемцитабина, композиции на их основе и их применение
TWI436775B (zh) 2007-08-24 2014-05-11 Oncotherapy Science Inc 以抗原胜肽合併化療藥劑治療胰臟癌
CN101525361B (zh) * 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
CA2890359A1 (en) 2012-11-07 2014-05-15 Zucai SUO Substituted gemcitabine aryl amide analogs and treatment methods using same
CA2891124A1 (en) 2012-11-13 2014-05-22 BoYen Therapeutics, Inc. Gemcitabine prodrugs and uses thereof
WO2015134334A1 (en) 2014-03-03 2015-09-11 Suo Zucai Gemcitabine analogs
WO2016078160A1 (zh) * 2014-11-17 2016-05-26 常州方圆制药有限公司 胞苷衍生物及其应用
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
EP4335496A2 (en) 2018-01-10 2024-03-13 Nucorion Pharmaceuticals, Inc. Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
WO2019152955A1 (en) 2018-02-02 2019-08-08 Steven Albert Everett Small molecule drug conjugates of gemcitabine monophosphate
US20210238214A1 (en) * 2018-04-26 2021-08-05 NanoMed Holdings Pty Ltd Gemcitabine amphiphile prodrugs
CN108864250A (zh) * 2018-05-29 2018-11-23 北京大学 一种FAPα酶敏感的吉西他滨前体药物及其制备方法和应用
EP3817732A4 (en) * 2018-08-03 2022-06-08 Cellix Bio Private Limited COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
WO2021011692A1 (en) 2019-07-17 2021-01-21 Nucorion Pharmaceuticals, Inc. Cyclic deoxyribonucleotide compounds
EP4143199A4 (en) 2020-04-21 2024-07-03 Ligand Pharm Inc NUCLEOTIDE PRODRUG COMPOUNDS
PL442924A1 (pl) * 2022-11-23 2024-05-27 Politechnika Śląska Prolek - glikokoniugat pochodny gemcytabiny, jako związek o działaniu przeciwnowotworowym, sposób otrzymywania i zastosowanie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
RU2131880C1 (ru) * 1992-06-22 1999-06-20 Эли Лилли Энд Компани Способ получения обогащенных бета-аномером нуклеозидов
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
NZ336676A (en) * 1997-01-24 2000-01-28 Norsk Hydro As Gemcitabine esters or amides useful as anti-cancer and anti-viral agents
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6624142B2 (en) * 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US6376470B1 (en) * 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
EP1567169A4 (en) * 2002-11-04 2009-10-21 Xenoport Inc GEMCITABINE PROMOTERS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
US7846436B2 (en) * 2003-11-28 2010-12-07 Chemgenes Corporation Oligonucleotides and related compounds

Also Published As

Publication number Publication date
EP1831237A1 (en) 2007-09-12
ES2310860T3 (es) 2009-01-16
MX2007007228A (es) 2007-08-14
RS50629B (sr) 2010-06-30
ATE405573T1 (de) 2008-09-15
MA29154B1 (fr) 2008-01-02
MY143677A (en) 2011-06-30
EA011868B1 (ru) 2009-06-30
AR055009A1 (es) 2007-08-01
US20090156547A1 (en) 2009-06-18
DK1831237T3 (da) 2008-10-27
CN101080417A (zh) 2007-11-28
PT1831237E (pt) 2008-09-22
WO2006065525A1 (en) 2006-06-22
ZA200705019B (en) 2008-10-29
US7691827B2 (en) 2010-04-06
AU2005316922A1 (en) 2006-06-22
CA2589850A1 (en) 2006-06-22
IL183666A0 (en) 2007-09-20
AU2005316922B2 (en) 2011-08-25
JP5022911B2 (ja) 2012-09-12
SI1831237T1 (sl) 2009-02-28
UA86119C2 (ru) 2009-03-25
PL1831237T3 (pl) 2009-01-30
KR20070086308A (ko) 2007-08-27
EA200701300A1 (ru) 2007-10-26
EP1831237B1 (en) 2008-08-20
JP2008524218A (ja) 2008-07-10
BRPI0519117A2 (pt) 2008-12-23
KR100874052B1 (ko) 2008-12-12
CA2589850C (en) 2012-05-01
CY1108447T1 (el) 2014-04-09
IL183666A (en) 2011-09-27
HK1109903A1 (en) 2008-06-27
TW200634023A (en) 2006-10-01
PE20060771A1 (es) 2006-09-23
DE602005009255D1 (de) 2008-10-02
TWI326687B (en) 2010-07-01
NZ554732A (en) 2010-09-30
CN101080417B (zh) 2011-01-19
NO20073368L (no) 2007-07-16

Similar Documents

Publication Publication Date Title
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
ME01992B (me) Jedinjenje diarilhidantoina
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
RS52632B (en) S-TRIAZOLYL ALFA-MERCAPTOACETANILIDE AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
MX2007005933A (es) Compuestos de acetamida como fungicidas.
IL185275A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
EA200800321A1 (ru) Ингибиторы гистондеацетилазы
UA94833C2 (en) Substituted bicyclolactams
TW200610531A (en) Phthalazine derivatives as PARP inhibitors
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
RS52323B (en) 2'-FLUORO-2'-DEOKSITETRAHIDROURIDINI KAO INHIBITORI CITIDIN DEAMINAZE
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
DK1817301T3 (da) Forstærkere af glutamat-receptorer
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
TW200745039A (en) Isotopically substituted pantoprazole
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
ATE541461T1 (de) Synergistische wirkstoffkombinationen
EA200800070A1 (ru) Производные 2-(1h-индолилсульфанил)ариламина
CO6251376A2 (es) Triazolilpiridina cetonas herbicidas
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
CY1111081T1 (el) Νεα μεθοδος συνθεσης του (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγκομελατινης
TW200714596A (en) Isotopically substituted proton pump inhibitors